Myriad Genetics, Inc. (NASDAQ:MYGN)

CAPS Rating: 5 out of 5

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

Recs

4
Player Avatar youstealing (< 20) Submitted: 7/15/2010 11:24:51 AM : Underperform Start Price: $15.58 MYGN Score: -42.44

no comments...

Report this Post Reply

Featured Broker Partners


Advertisement